Colonic Cancer
32
2
3
20
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
9.4%
3 terminated out of 32 trials
87.0%
+0.4% vs benchmark
16%
5 trials in Phase 3/4
15%
3 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 20 completed trials
Clinical Trials (32)
Abdominal Massage After Colon Surgery for Cancer
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Evaluating Online Messages About Colon Cancer Screening
Butyrophilins Role in Colon Cancer
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial
Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia
Split-dose Versus Single-dose Bowel Preparation for Colonoscopy
EMI-137 in Laparoscopic Colonic Resections
Endocuff With or Without AI-assisted Colonoscopy
Home-based HIIT to Improve CRC Survivorship: Feasibility and Relationship With Novel Surrogate Biomarkers of CRC Recurrence
Chinese Colorectal Cancer Database
R vs L Lateral Decubitus Positioning in Colonoscopy
Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer
Aquamin and Prevention of Colon Cancer
Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases
INtracorporeal Versus EXtracorporeal Anastomosis in Robotic Right Colectomy
National Registry of Liver First Approach
Open Versus Laparoscopic Right Hemicolectomy for Right Colon Cancer